Conclusions
Data from this study show that there is no difference in absorption rate and effect between the two preparations of rasagiline. All subjects showed good tolerance of both preparations without any serious or unexpected adverse reactions. According to the relevant provisions of NMPA guidelines, the two tablets were considered bioequivalent for single dosing under fasting and postprandial conditions.